Education
About Us
Working with TipRanks
Follow Us
PureTech Health PLC (GB:PRTC)
LSE:PRTC
Total Valuation
PureTech Health has a market cap or net worth of £346.83M. The enterprise value is 798.02M.
Market Cap£346.83M
Enterprise Value798.02M
Share Statistics
PureTech Health has 240,189,450 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding240,189,450
Owned by Insiders3.43%
Owned by Institutions0.11%
Financial Efficiency
PureTech Health’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is -27.95%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)-27.95%
Return on Capital Employed (ROCE)-0.24
Revenue Per Employee53.94K
Profits Per Employee347.27K
Employee Count80
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PureTech Health is 9.47. PureTech Health’s PEG ratio is 0.59.
PE Ratio9.47
PS Ratio0.00
PB Ratio1.66
Price to Fair Value1.22
Price to FCF-4.98
Price to Operating Cash Flow-5.04
PEG Ratio0.59
Income Statement
In the last 12 months, PureTech Health had revenue of 4.32M and earned 53.51M in profits. Earnings per share was 0.00.
Revenue4.32M
Gross Profit4.32M
Operating Income-136.09M
Pretax Income23.77M
Net Income53.51M
EBITDA37.38M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -134.37M and capital expenditures -11.00K, giving a free cash flow of -134.38M billion.
Operating Cash Flow-134.37M
Free Cash Flow-134.38M
Free Cash Flow per Share-0.56
Dividends & Yields
PureTech Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.93
52-Week Price Change-35.29%
50-Day Moving Average130.59
200-Day Moving Average145.40
Relative Strength Index (RSI)66.87
Average Volume (3m)335.96K
Important Dates
PureTech Health upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateApr 30, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
PureTech Health as a current ratio of 9.33, with Debt / Equity ratio of 8.64%
Current Ratio9.33
Quick Ratio9.33
Debt to Market Cap<0.01
Net Debt to EBITDA-6.91
Interest Coverage Ratio-13.56
Taxes
In the past 12 months, PureTech Health has paid -4.01M in taxes.
Income Tax-4.01M
Effective Tax Rate-0.17
Enterprise Valuation
PureTech Health EV to EBITDA ratio is 6.65, with an EV/FCF ratio of -1.85.
EV to Sales57.58
EV to EBITDA6.65
EV to Free Cash Flow-1.85
EV to Operating Cash Flow-1.85
Balance Sheet
PureTech Health has £367.31M in cash and marketable securities with $22.36M in debt, giving a net cash position of -£344.95M billion.
Cash & Marketable Securities£367.31M
Total Debt$22.36M
Net Cash-£344.95M
Net Cash Per Share-£1.44
Tangible Book Value Per Share£1.51
Margins
Gross margin is -7193.44%, with operating margin of -3154.00%, and net profit margin of 1240.09%.
Gross Margin-7193.44%
Operating Margin-3154.00%
Pretax Margin550.96%
Net Profit Margin1240.09%
EBITDA Margin866.33%
EBIT Margin783.57%
Analyst Forecast
The average price target for PureTech Health is £455.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target£455.00
Price Target Upside218.18% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast38.80%
EPS Growth Forecast―